Orphenadrine Citrate

Product NDC
66336-554
11-digit product format
663360554
Labeler code
66336
Product ID
66336-554_4a306212-0548-4ad5-9885-2198944bc6f5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Orphenadrine Citrate
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Dispensing Solutions, Inc.
Application
ANDA040284
Marketing category
ANDA
Marketing start
1998-06-19
Marketing end
0000-00-00
Substance
ORPHENADRINE CITRATE
Active strength
100 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
66336-554-142019-11-27C16284748780-19855d018-d3eb-cd31-e053-dbdaa90ab51aOrphenadrine Citrate Extended-Release Tablets Gavis Pharmaceuticals, LLC.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66336-554-14Orphenadrine Citrate14 in 1 BOTTLETABLET, EXTENDED RELEASE142

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
66336-554ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [DISPENSING SOLUTIONS, INC.]2Legacy NDC, 1 package rows20130724_c8dcda72-efd3-4203-8cc3-f6121cfdd5b0.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
994521orphenadrine citrate 100 MG 12HR Extended Release Oral TabletPSNc8dcda72-efd3-4203-8cc3-f6121cfdd5b02
99452112 HR orphenadrine citrate 100 MG Extended Release Oral TabletSCDc8dcda72-efd3-4203-8cc3-f6121cfdd5b02
994521orphenadrine citrate 100 MG 12 HR Extended Release Oral TabletSYc8dcda72-efd3-4203-8cc3-f6121cfdd5b02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
66336-554-146633605541414 in 1 BOTTLEHistorical